Services
Assessment/Pre-treatment
- Screening for mental disorders
- Outreach to persons in the community
- Professional interventionist/educational consultant
- Screening for tobacco use
- Comprehensive substance use assessment
- Interim services for clients
- Screening for substance use
Transitional Services
- Naloxone and overdose education
- Aftercare/continuing care
Age Groups Accepted
Facility Vaping Policy
- Vaping permitted in designated area
Treatment Approaches
- Brief intervention
- Relapse prevention
- Telemedicine/telehealth therapy
- Substance use disorder counseling
Testing
- Metabolic syndrome monitoring
- Drug and alcohol oral fluid testing
- Breathalyzer or blood alcohol testing
- HIV testing
- Drug or alcohol urine screening
- Testing for Hepatitis C (HCV)
External Source of Medications Used for Alcohol Use Disorder Treatment
- Other contracted prescribing entity
- In-network prescribing entity
- No formal relationship with prescribing entity
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
- Regular outpatient treatment
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
Type of Alcohol Use Disorder Treatment
- This facility administers/prescribes medication for alcohol use disorder
Recovery Support Services
- Assistance with obtaining social services
- Mentoring/peer support
Facility Operation (e.g., Private, Public)
- Private for-profit organization
Type of Opioid Treatment
- Relapse prevention with naltrexone
- Buprenorphine maintenance
- Prescribes naltrexone
- Prescribes buprenorphine
Ancillary Services
- Integrated primary care services
- Case management service
Type of Care
Education and Counseling Services
- Substance use disorder education
- Individual counseling
- Group counseling
- Marital/couples counseling
- Smoking/vaping/tobacco cessation counseling
Opioid Medications used in Treatment
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
Gender Accepted
Pharmacotherapies
- Buprenorphine with naloxone
- Naltrexone (oral)
- Buprenorphine (extended-release, injectable)
- Nicotine replacement
- Clonidine
- Non-nicotine smoking/tobacco cessation
- Acamprosate (Campral®)
- Medication for mental disorders
License/Certification/Accreditation
- State department of health
- State Substance use treatment agency
- Drug Enforcement Agency (DEA)
Facility Smoking Policy
- Smoking permitted in designated area
Payment/Insurance/Funding Accepted
- Private health insurance
- Medicaid
- Medicare
- Federal military insurance (e.g., TRICARE)
- Cash or self-payment
- Federal, or any government funding for substance use treatment programs
Location
199 Stratton Road, Suite 1, Rutland, VT 5701
Phone: (866) 453-5835
Website: http://www.bradfordpsychiatric.com/
← All programs in Rutland
7 Court Square, Rutland, VT
232 West Street, Rutland, VT
35 Washington Street, Rutland, VT
45 Union Street, Rutland, VT
10 Engrem Avenue, Rutland, VT
78 South Main Street, Rutland, VT